Since phosphorylation of most Ca2+-handling proteins is altered in many models of experimental heart failure and this might lead to increased Ca2+ leakage, we also examined the effects of PG-LPS treatment on the phosphorylation of phospholamban (PLN) at Thr-17, which is known to be mediated by CaMKII [19]. The gene discussed is PLN; the disease is heart failure.